Third Arc Bio is a Biotech company based in Boston. It has raised $165M in total funding. Latest round: Series A.
Third Arc Bio is a Biotech company based in Boston. Third Arc Bio has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Third Arc Bio runs through 2024; nothing later has been disclosed. Investors on record include Vida Ventures, Cormorant Asset Management, Hillhouse Investment, Omega Funds, Goldman Sachs Alternatives, BVF Partners LP and 8 others. 14 distinct backers are named across the disclosed rounds.
Round data for Third Arc Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boston and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026